Treatment Clinical Trial
Official title:
Determining the Validity, Reliability and Responsiveness of Cognitive Exercise Therapy Approach Scale in Patients With Chronic Neck Pain
Verified date | March 2020 |
Source | Eastern Mediterranean University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study was to determine the validity, reliability and sensitivity of the Cognitive Exercise Therapy Approach Scale in patients with neck pain.
Status | Completed |
Enrollment | 199 |
Est. completion date | January 24, 2020 |
Est. primary completion date | January 24, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Individuals aged between 18-65 years - Neck pain VAS out of 3 and above which individuals - Individuals who have neck pain for more than 3 months Exclusion Criteria: - Patients with previous neck surgery history - Not willing to participate in the study - Attract trouble understanding for filling scale |
Country | Name | City | State |
---|---|---|---|
Cyprus | Özge Sahin | Famagusta |
Lead Sponsor | Collaborator |
---|---|
Eastern Mediterranean University |
Cyprus,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cognitive Exercise Therapy Approach Scale (BETY) | The biopsychosocial process associated with the neck pain will be evaluated by the 'Cognitive Exercise Therapy Approach Scale'. The scale consists of 30 items. The scale was scored using a 5-point Likert system. Every question; No in no time: 0, Yes rarely: 1, Yes sometimes: 2, Yes often: 3, Yes is always scored as 4: and gives a total score of 30 items. High score means low biopsychosocial status assessment is "bad |
Change from the baseline will be assesed at the first week and at the third week. | |
Secondary | Neck Disability Index (NDI) | It is used to assess the disability caused by neck pain. The index consists of 10 chapters including the severity of pain, personal care, lifting, reading, headache, concentration, working life, driving, sleep and leisure time. There are 6 responses for each section, 0 (no pain and no functional limitation) and 5 (worst pain and maximum limitation). There was no apology between 0-4 points in the NDI, mild disability between 5-14 points, moderate disability between 15-24 points, severe apology between 25-34 points and full disability over 35 points . The Turkish validity and reliability study was conducted by Aslan et al. | At the beginning and 2 weeks after the start of treatment | |
Secondary | Arm, Shoulder and Hand Problems Questionnaire (DASH) | It is a scale used to evaluate the functional disability associated with upper extremity. The scale consists of three parts. DASH has a total of 30 questions and includes 8 questions for people who are engaged in work and social activities. In case of not answering more than 3 questions, the questionnaire is considered invalid. Response options in scale are between 1 and 5. Scoring for each section is calculated as 0-100. High scores indicate serious activity limitations . The scale is valid, reliable and sensitive to changes. The Turkish cultural adaptation was also made and the scale was found to be valid and reliable for the Turkish version. | At the beginning and 2 weeks after the start of treatment | |
Secondary | Hospital Anxiety and Depression Scale (HADS) | The area of use of the scale is not to diagnose, but to reveal the depression and anxiety associated with existing diseases. It has been widely used in a variety of somatic, psychiatric and primary care populations and in many chronic diseases such as musculoskeletal, cancer, end-stage renal disease, and has been found to be able to measure depression and anxiety significantly . It is a 14-item scale consisting of seven anxiety-related subscales (HADS-A) and depression subscale (HADS-D). Each question is scored between 0 and 3 and is interpreted according to the total score. Although the total score indicates the increased level of anxiety and depression, it can be interpreted as being 'normal' between 0-7, being between 8-10, 'borderline normal', and between 11-21 being 'abnormal'. The Turkish validity and reliability study was conducted by Aydemir et al. | At the beginning and 2 weeks after the start of treatment | |
Secondary | Short Form-36 (SF-36) | This questionnaire, which evaluates the quality of life of the person, consists of 36 questions on eight sub-scales: physical function, physical role restriction, emotional role restriction, body pain, social function, mental health, vitality, and general health. The scores are scored separately for each subscale and the scores range from 0 to 100. 100 points indicate good health status, while 0 points indicate poor health status . The reliability and validity study of Turkish by Koçyigit et al . | At the beginning and 2 weeks after the start of treatment | |
Secondary | Visual Analogue Scale (VAS) | The pain intensity of individuals was questioned by Vizel Analog Scale. VAS is a method used in numerical form to quantify non-measured values. It is often preferred because it can be easily applied and repeated in a short time. The parameter to be evaluated in a horizontal line of 10 centimeters is written to define both endpoints and the patient is asked to mark the appropriate point for the parameter evaluated on this 10-centimeter line. The severity of the patient's pain is determined by measuring the length of the distance from the point of pain to the point determined by the patient | At the beginning, and 2 weeks after the start of treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05243134 -
The Influence of Anatomic Deformities on the Clinical Efficacy in the Patients With Patellar Dislocation
|
||
Completed |
NCT02486874 -
Clinical Evaluation of PoreSkin
|
Phase 1 | |
Active, not recruiting |
NCT04592640 -
Stem Cells for Uremic Calciphylaxis Patients
|
N/A | |
Recruiting |
NCT04599686 -
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer
|
N/A | |
Recruiting |
NCT03351842 -
Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%
|
Phase 2 | |
Completed |
NCT02782442 -
Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)
|
N/A | |
Completed |
NCT03439930 -
The Effect of Balance Training on Neuromuscular Control in Subjects With CAI
|
N/A | |
Not yet recruiting |
NCT05537155 -
Buccal Acupuncture for Delirium Treatment in Older Patients Recovering From Orthopedic Surgery
|
N/A | |
Recruiting |
NCT02971982 -
PCD Versus RCD for the Treatment of Patients With Waldenstrom's Macroglobulinemia
|
Phase 1/Phase 2 | |
Completed |
NCT02820272 -
Water for Reducing Pain in Negative Pressure Wound Therapy
|
Phase 2 | |
Completed |
NCT00984958 -
Bulkamid Treatment of Stress Incontinence in Women With Urinary Stress Incontinence and Not Suitable to TVT-procedure
|
N/A | |
Completed |
NCT00575224 -
Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9
|
Phase 4 | |
Completed |
NCT00164307 -
Assisting Children With Prenatal Alcohol Exposure in Developing Peer Friendships
|
Phase 1/Phase 2 | |
Completed |
NCT00164528 -
Intervening With Children/Adolescents With FAS/ARND
|
Phase 1/Phase 2 | |
Recruiting |
NCT04603586 -
Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses
|
N/A | |
Recruiting |
NCT03375424 -
Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany
|
N/A | |
Not yet recruiting |
NCT04062370 -
Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion
|
Phase 4 | |
Not yet recruiting |
NCT02931136 -
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
|
Phase 4 | |
Completed |
NCT04661228 -
Diagnostic Survey of Mental and Substance Use Disorders in HUNT (PsykHUNT)
|
||
Recruiting |
NCT03365141 -
Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo
|
N/A |